1. Statins Counter the Effects of Hyperlipidemia on iNKT Cells

   • Joel Linden

   EDITORIAL 29 April 2012 Pages: 277 - 279

   

2. Beyond Hyperglycemia in Diabetes: Role of Statin Treatment on Thrombogenesis Triggered by Inflammation

   • Francesca Perego
   • Giovanni Davì

   EDITORIAL 15 May 2012 Pages: 281 - 284

   

3. Relaxant Effect of a Water Soluble Carbon Monoxide-Releasing Molecule (CORM-3) on Spontaneously Hypertensive Rat Aortas

   • Paola Failli
   • Alfredo Vannacci
   • Emanuela Masini

   OriginalPaper 06 July 2012 Pages: 285 - 292

   

4. Statin-Induced Immunomodulation Alters Peripheral Invariant Natural Killer T-cell Prevalence in Hyperlipidemic Patients

   • Evangelia Nakou
   • Prodromos Babageorgakas
   • Dimitrios A. Stakos

   OriginalPaper 24 March 2012 Pages: 293 - 299

   

5. Impact of Statins on the Coagulation Status of Type 2 Diabetes Patients Evaluated by a Novel Thrombin-Generation Assay

   • P. Ferroni
   • D. Della-Morte
   • F. Guadagni

   OriginalPaper 12 April 2012 Pages: 301 - 309

6. The Use of ω-3 Poly-Unsaturated Fatty Acids in Heart Failure: A Preferential Role in Patients with Diabetes

   • Pedram Kazemian
   • Seyyed M. R. Kazemi-Bajestani
   • Gavin Y. Oudit

   ReviewPaper 30 May 2012 Pages: 311 - 320

   

7. High Molecular Weight Calmodulin-Binding Protein: 20 Years Onwards—A Potential Therapeutic Calpain Inhibitor

   • Sreejit Parameswaran
   • Rajendra K. Sharma

   ReviewPaper 16 May 2012 Pages: 321 - 330

   

8. Stroke Prevention in Atrial Fibrillation: Managing the Risks in Light of New Oral Anticoagulants

   • John E. Strobeck

   ReviewPaper 25 May 2012 Pages: 331 - 338

   

9. Importance of Blood Rheology in the Pathophysiology of Atherothrombosis

   • Aimee Q. Cowan
   • Daniel J. Cho
   • Robert S. Rosenson

   OriginalPaper 21 July 2012 Pages: 339 - 348

   

10. Study Design, Rationale, and Baseline Characteristics: Evaluation of Fenofibric Acid on Carotid Intima-Media Thickness in Patients with Type IIb Dyslipidemia with Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial

    • Michael Davidson
    • Robert S. Rosenson
    • James Stolzenbach

    OriginalPaper Open access 24 May 2012 Pages: 349 - 358

    

11. New Challenges Ahead for the Newer Oral Thrombin Inhibitors that Aim at Replacing Warfarin in Clinical Practice—Any Role for Scientific Societies in the Debate?

    • Juan-Carlos Kaski

    ISCP PRESIDENT'S LETTER 05 May 2012 Pages: 359 - 360